Watch the 22 sessions from SOSV Climate Tech Summit!

Pannex Therapeutics is a pioneer biopharmaceutical company totally focused on the development of a novel therapeutic class of Pannexin 1 channel (Panx1) blockers. Pannex is developing a platform of small molecules that blocks this exciting new pharmacological target, Panx1 channels. With potential applications in many therapeutic areas, the initial focus is on chronic pain treatment and the prevention of opioid addiction.